• District of Columbia: President Biden on Monday announced he will invoke the Defense Production Act to give HHS authority to invest in domestic manufacturing of essential medical supplies and medical countermeasures. HHS plans to invest $35 million to domestically produce starting materials for sterile injectable medicines and the Department of Defense will release a report on how to strengthen pharmaceutical supply chain resilience. Biden also announced the creation of the Council on Supply Chain Resilience, which will be co-chaired by the National Security Advisor and National Economic Advisor and will work "to ensure that our supply chains remain secure, diversified, and resilient in the future." (Frieden, MedPage Today, 11/27; AHA News, 11/27)
• Ohio: The Cleveland Clinic on Monday announced it will partner with Canon Inc. to establish a comprehensive imaging research center within the Cleveland Innovation District. The Clinic's partnership with Canon will include a cross-institutional team of clinician-scientists, researchers, and engineers who will work towards developing sophisticated imaging technologies. The research will specifically focus on cardiology, neurology, and musculoskeletal medicine. (Bennett, Crain's Cleveland Business/Modern Healthcare, 11/27)
• Maryland: FDA has issued a recall of cinnamon-flavored varieties of applesauce sold under the brand names WanaBana, Schnucks, and Weis, after they were linked to lead poisoning symptoms in 52 children. According to FDA, children ages four years and younger presented with lead poisoning symptoms across 25 states. FDA said it found 2.18 parts per million of lead in the pouches, which is more than 200 times the levels proposed by the agency in draft guidance for baby food. The products are still on shelves in multiple states, FDA said. (Rubin, Axios, 11/24)

Explore our toolkit with insight on the future healthcare supply chain, including case studies from high-performing providers and suppliers.